CALGARY, AB, October 18, 2022 /CNW/ – High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets, is pleased to announce that its Colorado-based subsidiary, NuLeaf Naturals (“NuLeaf”), has had its Full Spectrum Hemp Multicannabinoid oil and plant-based softgels with delta-9 tetrahydrocannabinol (“Delta 9”), cannabichromene (“CBC”), cannabidiol (“CBD”), cannabigerol (“CBG”) and cannabinol (“CBN”) listed for sale in Ontario.  This listing comes after NuLeaf received approval from the Ontario Cannabis Store (“OCS”) to list these additional products in the OCS’s Fall Product call of 2022.

The oil will be available in 1800 ml containers at a concentration of 12 mg for each of the listed five cannabinoids, while the plant-based softgels will be available in packages of 120, each softgel containing 3 mg of each of the five listed cannabinoids.

“I am thrilled to finally share that the highly anticipated NuLeaf Naturals Multicannabinoid products are now available for all licensed cannabis retailers to stock in Ontario, Canada’s largest province, and should be available to consumers in the coming days at our Canna Cabana store network and through other licensed cannabis retailers. For some time now Canadian CBD customers have been reaching out to our team in the US asking when these products will become available north of the border; well, that wait is now over. While we are starting in Ontario, we look forward to launching these trail-blazing Multicannabinoid product lines in other Canadian provinces in the near future. I am pleased to announce that as of today NuLeaf has become High Tide’s first U.S.-based CBD subsidiary to have its products available for order in Canada through the OCS,” said Raj Grover, President and Chief Executive Officer of High Tide. “Since its founding in 2014, NuLeaf has been committed to creating the world’s highest quality cannabinoid products in their most pure and potent form. These Multicannabinoid oils and softgels contain a unique combination of five cannabinoids that is unparalleled in Canada. This one-of-a-kind product formulation sets NuLeaf apart from its competition and will help us continue to chip away at the illicit market share of CBD sales in Ontario and other Canadian provinces as these product launches continue.” added Mr. Grover.

About NuLeaf Naturals

Founded in 2014 in Denver, Colorado, NuLeaf Naturals is one of America’s leading cannabinoid companies. Since inception, NuLeaf has been committed to creating the world’s highest quality cannabinoid products in their most pure and potent form. NuLeaf’s products are produced at a cGMP-certified facility enabling them to manufacture groundbreaking cannabinoid formulations while reaching beyond the highest levels of regulatory compliance. Their cannabinoid products are sold direct-to-consumer from their website and are also available at bricks-and-mortar stores across the U.S. NuLeaf is committed to creating safe, consistent, and effective products and has proudly received over 25,000 verified 5-star customer reviews through its e-commerce platform.

For more information about NuLeaf, please visit www.nuleafnaturals.com.

ABOUT HIGH TIDE

High Tide is a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets. The Company is the largest non-franchised recreational cannabis retail chain in Canada as measure by revenue, with 140 current locations spanning British Columbia, Alberta, Saskatchewan, Manitoba and Ontario. The Company is also North America’s first cannabis discount club retailer, under the Canna Cabana banner, which is the single-largest cannabis retail brand in Canada, with additional locations under development across the country. High Tide’s portfolio also includes retail kiosks and smart locker technology – Fastendr. High Tide has been serving consumers for over a decade through its established e-commerce platforms, including Grasscity.com, Smokecartel.com, Dailyhighclub.com, and Dankstop.com and more recently in the hemp-derived CBD space through Nuleafnaturals.com, FABCBD.com, BlessedCBD.co.uk, BlessedCBD.de, and Amazon United Kingdom, as well as its wholesale distribution division under Valiant Distribution, including the licensed entertainment product manufacturer Famous Brandz. High Tide was featured in the annual Report on Business Magazine’s ranking of Canada’s Top Growing Companies in both 2021 and 2022 and was named as one of the top 10 performing diversified industries stocks in the 2022 TSX Venture 50. High Tide’s strategy as a parent company is to extend and strengthen its integrated value chain while providing a complete customer experience and maximizing shareholder value.

For more information about High Tide, please visit www.hightideinc.com and its profile pages on SEDAR at www.sedar.com and EDGAR at www.sec.gov.

Neither the TSX Venture Exchange (the “TSXV”) nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events.

The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: the Company’s business objectives and milestones and the anticipated timing of, and costs in connection with, the execution or achievement of such objectives and milestones (including, without limitation, proposed acquisitions); the Company’s future growth prospects and intentions to pursue one or more viable business opportunities; the development of the Company’s business and future activities following the date hereof; expectations relating to market size and anticipated growth in the jurisdictions within which the Company and NuLeaf may from time to time operate or contemplate future operations;  expectations with respect to economic, business, regulatory and/or competitive factors related to the Company and NuLeaf or the cannabis industry generally; the market for the Company and NuLeaf’s current and proposed product offerings, as well as the Company and NuLeaf’s ability to capture market share; the Company’s strategic investments and capital expenditures, and related benefits; the distribution methods expected to be used by the Company to deliver its product offerings; the competitive landscape within which each the Company and NuLeaf operates and the Company and NuLeaf’s market share or reach; the performance of the Company’s business and the operations and activities of the Company; the Company adding the number of additional cannabis retail store locations the Company proposes to add to the Company’s business upon the timelines indicated herein, and the Company remaining on a positive growth trajectory; the Company building upon its existing momentum in the international hemp-derived CBD and consumption accessories e-commerce sectors; the Company and NuLeaf continuing to integrate and expand its CBD brands; the Company completing the development of its cannabis retail stores; the Company’s ability to obtain, maintain, and renew or extend, applicable authorizations, including the timing and impact of the receipt thereof; the realization of cost savings, synergies or benefits from the Company’s recent and proposed acquisitions, and the Company’s ability to successfully integrate the operations of any business acquired within the Company’s business; the Company developing and launching Cabana Cannabis Co. white label products in the jurisdictions; Cabana Club loyalty program membership continuing to increase; the Company’s expectations from its Cabana Cannabis Co. white label products;  NuLeaf’s ability to successfully launch multicannabinoid product lines in the jurisdictions and on the timelines outlined herein and such products achieving the results disclosed herein; NuLeaf’s ability to successfully maintain its products availability for sale in Canada through the OCS; the Company becoming the largest revenue-generating cannabis company reporting in Canada dollars; the anticipated effects of the Cabana elite program on the business and operations of the Company; the Company’s ability to extend and strengthen its value chain, provide required customer experience and maximize shareholders’ value; the Company continuing to grow its online retail portfolio through further strategic and accretive acquisitions.

Forward-looking information in this press release are based on certain assumptions and expected future events, namely: current and future members of management will abide by the Company’s business objectives and strategies from time to time established by the Company;  the Company will retain and supplement its board of directors and management, or otherwise engage consultants and advisors having knowledge of the industries (or segments thereof) within which the Company may from time to time participate; the Company will have sufficient working capital and the ability to obtain the financing required in order to develop and continue its business and operations; the Company will continue to attract, develop, motivate and retain highly qualified and skilled consultants and/or employees, as the case may be; no adverse changes will be made to the regulatory framework governing cannabis, taxes and all other applicable matters in the jurisdictions in which the Company conducts business and any other jurisdiction in which the Company may conduct business in the future; the Company will be able to generate cash flow from operations, including, where applicable, the distribution and sale of cannabis and cannabis products; the Company and NuLeaf will be able to execute on its business strategies as anticipated; the Company and NuLeaf will be able to meet the requirements necessary to obtain and/or maintain authorizations required to conduct the business; general economic, financial, market, regulatory, and political conditions will not negatively affect the Company and NuLeaf or their respective businesses; the Company and NuLeaf will be able to successfully compete in the cannabis industry; cannabis prices will not decline materially; the Company and NuLeaf will be able to effectively manage anticipated and unanticipated costs; general market conditions will be favourable with respect to the Company and NuLeaf’s future plans and goals; the Company will build upon its existing momentum in the international hemp-derived CBD and consumption accessories e-commerce sectors; the Company and NuLeaf will continue to integrate and expand its CBD brands; the Company will add the additional cannabis retail store locations to the Company and NuLeaf’s business and remain on a positive growth trajectory; the Company will complete the development of its cannabis retail stores; NuLeaf’s will successfully launch multicannabinoid product lines in the jurisdictions and on the timelines outlined herein and such products will achieve the results disclosed herein; NuLeaf’s will successfully maintain its products availability for sale in Canada through the OCS; the Company will become the largest revenue-generating cannabis company reporting in Canada dollars; Cabana Club loyalty program membership will continue to increase; the Company will continue to develop and launch Cabana Cannabis Co. white label products in the jurisdictions and on the timelines outlined herein and such products will achieved the results disclosed herein; the Cabana elite program will have the anticipated effect on the business and operations of the Company; the Company will be able to extend and strengthen its value chain, provide required customer experience and maximize shareholders’ value; and the Company will continue to grow its online retail portfolio through further strategic and accretive acquisitions.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to:  the Company’s inability to attract and retain qualified members of management to grow the Company’s business and its operations; unanticipated changes in economic and market conditions or in applicable laws; the impact of the publications of inaccurate or unfavourable research by securities analysts or other third parties; interruptions or shortages in the supply of cannabis from time to time available to support the Company and NuLeaf’s operations from time to time; unanticipated changes in the cannabis industry in the jurisdictions within which the Company and NuLeaf may from time to time conduct its business and operations, including the Company and NuLeaf’s inability to respond or adapt to such changes; the Company’s inability to secure or maintain favourable lease arrangements or the required authorizations necessary to conduct the business and operations and meet its targets; the Company’s inability to secure desirable retail cannabis store locations on favourable terms; risks relating to projections of the Company and NuLeaf’s operations; the Company and NuLeaf’s inability to effectively manage unanticipated costs and expenses; risk that Cabana Club loyalty program membership will decrease and/or plateau; risk that the Company will be unable to develop and launch Cabana Cannabis Co. white label products in the jurisdictions and/or that such products will be unable to achieve the results disclosed herein; risk that the Company or NLleaf will be unable to increase its revenue profile;  risk that the Company or NuLeaf will be unable to expand in the jurisdictions in which each proposes to expand; risk that the Company or NuLeaf will be unable to continue to integrate and expand its CBD brands; risk that the Company will be unable to grow its online retail portfolio through further strategic and accretive acquisitions; risk that the Company will be unable to add additional cannabis retail store locations to the Company’s business and remain on a positive growth trajectory; risks that the Company will be unable to complete the development of any or all of its cannabis retail stores; risk that the Company will not become the largest revenue-generating cannabis company reporting in Canada dollars; risk that the Cabana elite program will not have the anticipated effect on the business and operations of the Company; risks surrounding the legality of Delta 9, CBC, CD, CBG, and CBN in jurisdictions in which the Company or NuLeaf proposes to sell these products; risks associated the Company being unable to extend and strengthen its value chain, provide required customer experience and maximize shareholders’ value; and  risks associated with inability to grow Company’s online retail portfolio through further strategic and accretive acquisitions.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

.

CONTACT INFORMATION
Media Inquiries
Omar Khan
Senior Vice President – Corporate and Public Affairs
High Tide Inc.
[email protected]inc.com

Investor Inquiries
Vahan Ajamian
Capital Markets Advisor

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 3, 2021 to its short form base shelf prospectus dated April 22, 2021.

Calgary, AB, September 1, 2022 / CNW / − High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets, is pleased to announce that further to its press releases dated July 7, 2022 and August 4, 2022, the Company has completed its acquisition (the “Acquisition”), through Companies’ Creditors Arrangement Act (“CCAA”) Proceedings, of the final retail cannabis location (the “Store”) out of the nine store portfolio for CAD$1.1 Million (the “Transaction”). The Store is located at 7555 Montrose Road in Niagara Falls, Ontario, and is situated in Niagara Square, an outlet mall anchored by numerous national big box and discount retailers.

For the three months ended April 30, 2022, collectively, the Store, along with the eight Choom locations that were previously acquired by High Tide, generated annualized revenue of CAD$10.2 million and annualized Adjusted EBITDA of CAD$1.3 million. The purchase price (inclusive of all nine Choom locations) represents 3.8x annualized Adjusted EBITDA for the three months ended April 30, 2022.

TRANSACTION DETAILS

The Acquisition was completed pursuant to the terms of a binding agreement dated June 28, 2022 (“Acquisition Agreement”). High Tide acquired the Store, including inventory, for CAD$1.1 Million, for approximately $300,000 in cash and by issuing 364,185 common shares of High Tide (each a “High Tide Share”) at a deemed price of $2.3375 per High Tide Share. Pursuant to the Acquisition Agreement, 70% of the High Tide Shares issued are subject to a four month hold.

The closing of the Acquisition remains subject to final approval from the TSXV.

ABOUT HIGH TIDE

High Tide is a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets. The Company is the largest non-franchised retailer of recreational cannabis in Canada, with 140 current locations spanning Ontario, Alberta, British Columbia, Manitoba, and Saskatchewan. The Company is also North America’s first cannabis discount club retailer, under the Canna Cabana banner, which is the single-largest cannabis retail brand in Canada with additional locations under development across the country. High Tide’s portfolio also includes retail kiosk and smart locker technology – Fastendr. High Tide has been serving consumers for over a decade through its established e-commerce platforms including Grasscity.com, Smokecartel.com, Dailyhighclub.com, and Dankstop.com and more recently in the hemp-derived CBD space through Nuleafnaturals.com, FABCBD.com, BlessedCBD.co.uk, BlessedCBD.de, and Amazon UK, as well as its wholesale distribution division under Valiant Distribution, including the licensed entertainment product manufacturer Famous Brandz. High Tide was featured in the third annual Report on Business Magazine’s ranking of Canada’s Top Growing Companies in 2021 and was named as one of the top 10 performing diversified industries stocks in the 2022 TSX Venture 50. High Tide’s strategy as a parent company is to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information about High Tide Inc., please visit www.hightideinc.com, its profile page on SEDAR at www.sedar.com, and its profile page on EDGAR at www.sec.gov.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include statements relating to: the anticipated effects of the Acquisition on the business and operations of High Tide; the suitability of the locations of the Store; and High Tide’s plans to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value..

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: High Tide’s financial condition and development plans do not change as a result of unforeseen events; there will continue to be a demand, and market opportunity, for High Tide’s product offerings; current and future economic conditions will neither affect the business and operations of High Tide nor High Tide’s ability to capitalize on anticipated business opportunities); the continued suitability of the location of the Store, although considered reasonable by management of High Tide at the time of preparation, may prove to be imprecise and result in actual results differing materially from those anticipated, and as such, undue reliance should not be placed on forward-looking statements.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the risks associated with the cannabis and CBD industries in general; the inability of High Tide to pursue more retail acquisitions in the future, the inability of High Tide to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value; the location of the Store no longer being a suitable location for continued operations for such store.

Forward-looking statements, forward-looking financial information and other metrics presented herein are not intended as guidance or projections for the periods referenced herein or any future periods, and in particular, past performance is not an indicator of future results and the results of High Tide in this press release may not be indicative of, and are not an estimate, forecast or projection of High Tide future results. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof, and thus are subject to change thereafter. High Tide disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Factors that could cause anticipated opportunities and actual results to differ materially include, but are not limited to, matters referred to above and elsewhere in High Tide’s public filings and material change reports, which are and will be available on SEDAR.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933 (the “1933 Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons (as defined in the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration is available.

CONTACT INFORMATION

Media Inquiries

Omar Khan

Senior Vice President – Corporate and Public Affairs

High Tide Inc.

[email protected]

Investor Inquiries

Vahan Ajamian

Capital Markets Advisor

High Tide Inc.

[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Large Format 14g Bags of Cookies Sun-Grown, Whole Flower Available This Month

DELTA, British Columbia, May 03, 2022 (GLOBE NEWSWIRE) — Today, Pure Sunfarms Corp. (“Pure Sunfarms”), a wholly-owned subsidiary of Village Farms International, Inc. (Nasdaq: VFF) and NOYA Cannabis Inc. (“NOYA”) announce that Cookies sun-grown flower will be available in Ontario this month. Pure Sunfarms is the licensed producer of record for Cookies sun-grown flower in Canada.

Using Cookies genetics and post-production processes, Pure Sunfarms grows and processes high-quality, whole flower for Cookies to the highest standards. Each batch is hang-dried and hand-trimmed to ensure the full potential of the flower is maintained. Grown in Pure Sunfarms 1.65 million square foot greenhouse space in British Columbia, consumers can expect to receive high-quality large format Cookies sun-grown strains at a differentiated price.

“Pure Sunfarms is one of the largest and best cannabis operations in the world, with a team of expert operators and cultivators,” said Ziad Reda, CEO of NOYA. “That’s why we’ve chosen them as our sun-grown partner in Canada, because we know that they will grow and process our Cookies flower to the same high standards our consumers know and love – but grown under the sun in beautiful British Columbia.”

“It’s an honour to be the sun-grown partner for one of the biggest cannabis brands in the world,” said Mandesh Dosanjh, President & CEO, Pure Sunfarms. “Our team knows what it takes to bring out the best in our flower. The Cookies genetics we’ve grown in our greenhouse have really thrived. We know sun-grown flower is the best flower – and now we get to bring these strains into the light for Cookies consumers to enjoy. They’re going to see great genetics, great quality, at great prices.”

NOYA and Pure Sunfarms are both leaders in craft and large-scale cannabis cultivation and production in Canada. Bringing together the highest standards, processes, and techniques, together they are able to run a successful operation and partnership to bring Cookies sun-grown flower to Ontario.

Cookies sun-grown, whole flower will be available for purchase in 14g bags in Ontario in the weeks ahead, starting with Georgia Pie and Lemonnade by Cookies strain, Medellin, and followed by GP20 in the weeks to follow.

About Cookies

Cookies, founded in 2010 by entrepreneur Berner and Bay Area breeder and cultivator Jai, is the most globally recognized cannabis company in the world. Cookies values the power of the plant and focuses on creating game-changing genetics. The company offers a collection of over 70 proprietary cannabis cultivars and more than 2,000 products. Cookies also actively works to enrich communities disproportionately impacted by the War on Drugs through advocacy and social equity initiatives. Headquartered in San Francisco, the company opened its first retail store in 2018 in Los Angeles, and has since expanded to over 45 retail locations in 17 markets across 5 countries. Cookies was named one of America’s Hottest Brands of 2021 by AdAge; the first cannabis brand to ever receive this accolade.

About Pure Sunfarms

Pure Sunfarms is one of the largest cannabis operations in the world, producing high-quality, BC-grown cannabis in 1.65 million square feet of greenhouse space in Delta, British Columbia. The company brings together decades of agricultural and legacy cultivation experience with best-in-class, large scale operational expertise, and is one of Canada’s top-selling brands.

The company has capacity to produce, sell, and distribute 112,500 kilograms of dried flower annually for Canadian recreational and international markets. Pure Sunfarms is currently converting a second greenhouse for cannabis production, which when complete is expected to bring annual output capacity to 150,000 kilograms.

Current supply agreements include the Ontario Cannabis Retail Corporation (OCRC) (operating as the Ontario Cannabis Store (OCS)), the BC Liquor Distribution Branch (BCLDB), Alberta Gaming, Liquor & Cannabis (AGLC), the Saskatchewan Liquor and Gaming Authority (SLGA), and the Manitoba Liquor and Lotteries Corporation. Pure Sunfarms also provides cannabis to other Licensed Producers in Canada, including its affiliate ROSE LifeScience in Québec. The company also has EU GMP certification.

Pure Sunfarms is the wholly-owned Canadian subsidiary of Village Farms International, Inc. (Nasdaq: VFF).

www.puresunfarms.com

About NOYA

Founded in Hamilton, Ontario in 2014, NOYA Cannabis Inc. is a licensed producer under the Cannabis Act. The company received its cultivation license in 2017, and its sales license in 2018. The company has positioned itself as a premium white label producer and is working with highly recognized cannabis brands in the world. The company’s mission is to distribute and cultivate premium craft cannabis to match the needs of the market.

Media Contact
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

CALGARY, Alberta, March 07, 2022 (GLOBE NEWSWIRE) — Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.DB, SUGR.WR, SUGR.WS, SUGR.WT) (OTCQB: SBUDD) (“Sugarbud” or the “Company”) is pleased to announce the launch of the Company’s first Cannabis 2.0 product – Krypto Chronic #2 1.0g Flower Rosin – and the Company’s first 10 x 0.35g multi-pack Pre-Roll format in Ontario.

Sugarbud Krypto Chronic #2 Flower Rosin | Sugarbud’s first flower rosin is an exceptional concentrate made through the solventless extraction of Sugarbud’s exclusive indica dominant hybrid genetic – Krypto Chronic #2.

Solventless extraction methods place a premium on maintaining the naturally occurring terpenes, flavors, aromas and cannabinoids throughout the entire process, ensuring that the full essence of the original dried flower is maintained. Sugarbud’s Krypto Chronic #2 flower rosin is another exceptional example of Sugarbud’s “House Style”, and embodies the same quality, consistency, flavor profiles and aromas consumers have come to expect from the Sugarbud Craft Cannabis Collection. Total THC will range between 60-70% with a total terpene profile of between 5-8%.

Sugarbud “Buddies” 10 x 0.35g Pre-Rolls | Caring is sharing responsibly with our new and convenient 10 x 0.35g “Buddies” Pre-Roll format. “Expertly crafted using only 100% dry flower and absolutely no trim, Sugarbud “Buddies” Pre-Rolls promise the same high quality experience consumers have come to expect from our very popular 3.5g dry flower products with the added convenience of a smaller easier to carry and easier to share packaging format,” commented Sugarbud President and CEO, John Kondrosky. The first product being launched under the new “Buddies” format will contain Sugarbud’s exclusive Bahama Blizzard #11 dry flower and consumers can expect the same well-defined aromas of sweet confectionary, pine, lemon citrus, floral and fuel found in the very successful 3.5g dry flower format. Total THC will range between 21-26% with a terpene profile of between 1-3%.

The Company has received initial purchase orders from the Ontario Cannabis Store (“OCS”) and expects their Krypto Chronic #2 Flower Rosin and Bahama Blizzard #11 10 x 0.35g Buddies Pre-Rolls to be available for purchase from private cannabis retailers throughout Ontario and online at OCS.ca in Spring 2022.

“Our partnership with the OCS continues to grow as we diversify and expand the product offering within our Craft Cannabis Collection, and we are delighted to be bringing these new and exciting formats to Ontario consumers,” concluded Mr. Kondrosky.

The OCS is Ontario’s only legal online retailer and is responsible for the wholesale distribution of recreational cannabis products to private retailers in the province.

About Sugarbud

“Hand-Crafted Cannabis for a New Era”

Sugarbud is a consumer-driven craft cannabis company focused on the cultivation and production of superior, select-batch, craft cannabis products. Our vision and mission are to become a trusted and well-respected consumer brand renowned for providing exceptional high-quality craft cannabis products to legal markets by delighting the most discerning of cannabis consumers.

The Sugarbud Craft Cannabis Collection offers consumers “Hand-Crafted Cannabis for a New Era”. The Company is proudly Albertan and is proud to share Western Canada’s long tradition of exceptional craft cannabis with the most discerning of enthusiasts. Sugarbud strives to define the intersection of product craftsmanship, quality, and value for consumers in the Canadian craft cannabis space.

Sugarbud Craft Cannabis products are currently available to adult recreational consumers in the Yukon Territory, British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and nationally to registered medical patients through MendoCannabis.ca. Sugarbud products are also distributed in the Province of Quebec through ROSE LifeScience Inc.’s (“ROSE“) pursuant to a previously announced Sales, Marketing, Supply and Distribution Agreement between ROSE and the Company.

We Take Pride.

We Take Our Time.

Experience The Difference.

CONTACTS:
John Kondrosky
Chief Executive Officer
Sugarbud Craft Growers Corp.
Phone: (604) 499-7847
E-mail: [email protected]

Investor Relations Contact
Chris Moulson
Chief Financial Officer
Sugarbud Craft Growers Corp.
Tel: (778) 388-8700
E-mail: [email protected]

Websites:
http://www.sugarbud.ca/
http://craftcannabiscollection.ca

Forward Looking and Cautionary Statements

This news release contains forward-looking statements. More particularly, and without limitation, this news release contains statements concerning: Sugarbud’s assessment of future plans, operations and cannabis cultivation and processing, including sales, marketing and distribution opportunities; product quality; the development, production, sale and distribution of Sugarbud’s Cannabis 2.0 and Pre-Roll products, including new product lines and the properties, characteristics and launch timing thereof; the expected timing of retail availability of new products; future growth; customer satisfaction; and the status of the Company’s partnership with OCS. When used in this document, the words “will,” “anticipate,” “believe,” “estimate,” “expect,” “intent,” “may,” “project,” “should,” and similar expressions are intended to be among the statements that identify forward-looking statements. The forward-looking statements are founded on the basis of expectations and assumptions made by Sugarbud. Forward-looking statements are subject to a wide range of risks and uncertainties, and although Sugarbud believes that the expectations represented by such forward-looking statements are reasonable, there can be no assurance that such expectations will be realized. Any number of important factors could cause actual results to differ materially from those in the forward-looking statements including, but not limited to: currently contemplated expansion and development plans may cease or otherwise change; production of cannabis may be lower than expected; ability to ship cannabis products may be lower than expected; demand for Sugarbud’s products may be lower than anticipated; results of production and sale activities; results of scientific research; changes in prices and costs of inputs; demand for labour; demand for products; failure of counter-parties to perform contractual obligations; failure to maintain consumer brand recognition and loyalty of customers; reliance on relationships with wholesalers and retailers for distribution of products and failure to maintain strategic business relationships; intense competition, including from illicit sources; uncertainty and continued evolution of markets; product liability litigation; reliance on information technology; infringement on intellectual property; failure to benefit from partnerships; sensitivity of end-customers to increased sales taxes and economic conditions; failure to comply with certain regulations; departure of key management personnel or inability to attract and retain talent; actions and initiatives of federal and provincial governments and changes to government actions, initiatives and policies and the execution and impact thereof; the ability to implement corporate strategies; the state of domestic capital markets; the ability to obtain financing; changes in general market conditions; industry conditions and events; the size of the medical marijuana market and the recreational marijuana market; government regulations, including future legislative and regulatory developments involving medical and recreational marijuana; construction delays; risks inherent in the agricultural business, such as insects, plant diseases and similar agricultural risks which can have a significant impact on the size and quality of the harvest of cannabis crops; competition from other industry participants; and other factors more fully described from time to time in the reports and filings made by Sugarbud with securities regulatory authorities. In addition, the Company cautions that current global uncertainty with respect to the spread of the COVID-19 virus, and variant strains of the virus, and its effect on the broader global economy may continue to have a significant negative effect on the Company. While the precise impact of the COVID-19 virus on the Company remain unknown, rapid spread of the COVID-19 virus may continue to have a material adverse effect on global economic activity, and can result in volatility and disruption to global supply chains, operations, mobility of people and the financial markets, which could affect interest rates, credit ratings, credit risk, inflation, business, financial conditions, results of operations and other factors relevant to the Company. Please refer to Sugarbud’s most recent annual information form and management’s discussion and analysis for additional risk factors relating to Sugarbud, which can be accessed under Sugarbud’s profile on www.sedar.com. Except as required by applicable laws, Sugarbud does not undertake any obligation to publicly update or revise any forward-looking statements.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Mississauga facility expected to begin treatment services in the Second Half of 2022 

First location selected as part of a nationwide buildout of NeonMind-branded clinics offering interventional psychiatry treatments

Vancouver, B.C. – February 17, 2022: NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FRA: 6UF) (“NeonMind” or the “Company”), an integrated drug development and wellness company focused on bringing innovative psychedelic-based treatments to people suffering from obesity and mental health disorders, announced today it has signed an agreement with SRx Health Solutions (“SRx”) to open the Company’s inaugural NeonMind specialty mental health clinic, located at the Queensway Professional Medical Centre in Mississauga, Ontario.

The Mississauga location is the first in NeonMind’s initiative to establish a national network of NeonMind-branded specialty clinics. These clinics will focus on delivering high-demand mental health treatments to underserved areas of Canada. The specialty services to be offered will incorporate innovative, evidence-based interventional psychiatric treatments for a variety of mood and anxiety disorders. The Mississauga clinic is expected to start seeing patients in the second half of 2022.

“Our first NeonMind specialty mental health clinic represents a significant milestone in our multi-pronged strategy to bring the therapeutic benefits of innovative, safe, and effective treatments to patients throughout Canada,” said Robert Tessarolo, President & CEO of NeonMind. “The demand for treatments to address depression and anxiety disorders in Ontario has grown significantly in recent years, yet there remains a supply bottleneck for newer modalities such as ketamine treatment and neurostimulation. Our strategic collaboration with SRx will enable us to purposefully and flexibly enhance access to these treatments for communities in need. We expect to launch additional clinic locations throughout the course of 2022 and beyond, as well as incorporate new treatments, such as psychedelics, as they are approved.”

The Mississauga location enables NeonMind to serve a rapidly growing patient population. Based on NeonMind’s internal estimates, the market for specialized medical services for mental health disorders in Ontario has grown at a CAGR of over 20% from 2017 to 2019. NeonMind’s specific Mississauga location serves an area of Ontario that has seen tremendous demand for specialized mental health services, representing approximately 10% of total demand in Ontario. Demand for specialized services in Mississauga has grown at a CAGR of over 30%, outpacing the overall Ontario market, based on NeonMind’s internal estimates from provincial medical data.

Mr. Brock Clancy, Vice President of Patient Services and Operations at SRx Health Solutions, stated, “The Mississauga location will be a monumental step in enhancing accessibility to cutting-edge treatment solutions. As the fastest growing healthcare services provider in Canada, SRx is committed to making healthcare simple, helping improve the wellness of Canadians, and being a vehicle of innovative change in this space. We are thrilled by our collaboration with NeonMind and look forward to furthering our commitment and helping deliver this type of service to those in need.”

The Queensway Professional Medical Centre is a professional medical building that provides a full range of healthcare services, including a pharmacy and laboratory services, and is equipped with abundant parking facilities and accessibility options. The facility is located on major commuter routes and across from Trillium Health Partners – Mississauga Hospital. NeonMind’s first specialty clinic will provide exceptional, quality services including multiple private, spacious and comforting treatment rooms, as well as a fully-equipped waiting room for patients and caregivers.

NeonMind’s inaugural specialty mental health clinic is located at 89 Queensway West, Suite 604, Mississauga, Ontario, L5B 2V2. More details will be released closer to the opening of the clinic. For more information related to NeonMind’s specialty clinics, please email [email protected].

The Company also announces the resignation of Amber Allen as Vice President of Sales effective January 17, 2022, which was in connection with the divestiture of the NeonMind consumer division assets.

About NeonMind Biosciences Inc.

NeonMind operates two divisions: (i) a pharmaceutical division engaged in drug development of psychedelic compounds with two lead psilocybin-based drug candidates targeting obesity; and (ii) a medical services division focused on launching specialty mental health clinics that integrate psychedelic therapeutics into traditional psychotherapy settings.

In its pharmaceutical division, NeonMind has two distinct psilocybin drug development programs targeting obesity. NeonMind’s lead candidate, NEO-001, employs psilocybin as an agonist at the serotonin 5- HT2A receptor, which is involved in the hallucinogenic effect of psychedelics. The Company’s second drug candidate, NEO-002, employs low-dose psilocybin as an agonist at the 5-HT2C receptor, which controls appetite.

NeonMind and its strategic partners are building NeonMind-branded specialty mental health clinics in Canada that incorporate evidence-based innovative interventional psychiatry treatments to address a variety of mental health needs. For more information on NeonMind, go to www.NeonMindBiosciences.com.

About SRx Health Solutions Inc.

SRx Health Solutions is Canada’s leading collaborative network of pharmacists and healthcare practitioners delivering innovative, sustainable, and integrated healthcare solutions. We proudly employ over 400 associates across Canada who support our 30+ pharmacies and 125+ clinics and are dedicated to providing exceptional care to patients. SRx is on a mission to enhance the wellness of Canadians, revolutionize healthcare, and ensure that all Canadians have access to equal, modern health services.

Rob Tessarolo, President & Chief Executive Officer, NeonMind Biosciences Inc.

[email protected]

Tel: 416-750-3101

Investor Relations:

KCSA Strategic Communications

Scott Eckstein/Tim Regan

[email protected]

Tel: 212-896-1210

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Vancouver, British Columbia–(Newsfile Corp. – February 3, 2022) – Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf“, “OILS“, or the “Company“), a federally regulated manufacturer and distributor of cannabis vapes and oils, is pleased to announce it has received approval from the Ontario Cannabis Store (“OCS“) to list the Company’s Glacial Gold products in Ontario. Wholly-owned by the Province of Ontario, the OCS is the sole distributor in the province and all Ontario retailers must purchase their product inventory through the OCS.

“We are thrilled for British Columbia’s #1 selling CBD focused vape to be available at cannabis retailers across Ontario this Spring,” said Paul Pedersen, CEO of Nextleaf. “Expanding distribution of Glacial Gold products into Ontario is a significant milestone for our Company and sets the stage for significant growth of our branded product sales. By leveraging Nextleaf’s patented distillation technology, Glacial Gold vapes and oils deliver unparalleled value to consumers.”

Glacial Gold Available in Ontario Spring 2022

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/5347/112658_72822c65e4e2e85e_001full.jpg

The OCS is listing Nextleaf’s SKUs in two core product categories; vape cartridges and distilled oils. The first products available this spring will be from Nextleaf’s award-winning prohibition-era brand Glacial Gold, including the Anytime Vape, and Distilled 30/30 Blend Oil.

Glacial Gold Anytime Vapes are formulated with a balanced 1:1 THC and CBD profile for consumers looking for a more moderate, anytime vape. Glacial Gold Distilled 30/30 Blend Oil features high-purity CBD and THC distillates in a base of organic coconut MCT oil for a premium consumption experience, without premium pricing. A clean tasting, and neutral oil allowing for greater flexibility in use and consumption occasions.

Glacial Gold products are expected to be available at retail stores across Ontario and at osc.ca starting May 2022. Learn more at www.Glacial.Gold.

Nextleaf Introduces New Vape Flavours in B.C.

Nextleaf’s wholly-owned subsidiary, Nextleaf Labs Ltd. (“Nextleaf Labs“), has completed a shipment to the British Columbia Liquor and Distribution Branch of its three new Glacial Gold vape SKUs, including two new flavours: Sunshine Punch and Sparkling Grape. The Company anticipates the product will be available for B.C. retailers to order in early February. Nextleaf Labs is a Top-10 supplier of vapes and oils in British Columbia¹.

Nextleaf Ships Glacial Gold Vapes and Distilled Oils to Nova Scotia

Nextleaf Labs has completed its first shipments of Glacial Gold CBD and THC products to the Nova Scotia Liquor Corporation (“NSLC“). Glacial Gold vapes and distilled oils will be available in February across Nova Scotia through NSLC cannabis stores.

Nextleaf Engages National Sales Agency

Nextleaf is pleased to announce it has engaged Cannavolve Inc. (“Cannavolve“) to provide field coverage at cannabis retailers and support the national rollout of Glacial Gold products. “Our field team, our co-founder & Partner Kye Melchert, and I are all extremely excited that Nextleaf has chosen Cannavolve as their national sales agency. We have a strong track record of building brands in Canada, and we look forward to being a part of Glacial Gold brand’s path to growth,” said Trace Hanlon, Partner and Director of Cannavolve.

Cannavolve has a wide network throughout every major provincial market in Canada and the partnership will help Nextleaf achieve further route-to-market efficiencies and position its award-winning prohibition-era brand, Glacial Gold as a national leader in the vape and CBD oil categories.

About Cannavolve Inc.

Cannavolve is an independent, recreational cannabis sales and marketing agency established to represent Licensed Producers and Licensed Processors of quality-assured cannabis, and global suppliers of cannabis accessories. Cannavolve offers a choice of national or regional licensed non-medicinal retail field coverage, innovative, compliant marketing solutions, and government board navigation services. By leveraging analytic data, extensive B2B experience and a best-in-class sales team, Cannavolve delivers results for our suppliers and retail partners through custom tailored commercial strategies and execution. Cannavolve operates nationally with regional offices in Montreal, Toronto, and Vancouver. For more information, visit www.Cannavolve.ca.

About Nextleaf®

Nextleaf is a federally regulated manufacturer and distributor of cannabis vapes and oils under its award-winning prohibition-era brand, Glacial Gold. The Company’s multi-patented ingredient processing technology transforms cannabis and hemp biomass into high-purity distillate at an industrial scale. Nextleaf is a low-cost producer of cannabis oils, and supplies THC and CBD ingredients to qualified wholesale partners across Canada. Nextleaf is the first publicly traded company to be issued a U.S. patent for the industrial extraction and purification of cannabinoids. The Company has been issued 17 U.S. patents, and over 90 patents globally, on cannabinoid processing including distillation and acetylation. Nextleaf develops proprietary cannabinoid-based formulations and delivery technology through its Health Canada Research Licence with sensory evaluation of cannabis via human testing. For more information, visit www.nextleafsolutions.com and www.Glacial.Gold.

Nextleaf Solutions trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange.

Follow the Company across social platforms: Twitter, LinkedIn, Facebook, Instagram.

Follow Glacial Gold across social platforms: Instagram, Twitter, Facebook.

For more information please contact:
Jason McBride, Corporate Development
604-283-2301 (ext. 219)
[email protected]

On behalf of the Board of Directors of the Company,
Paul Pedersen, CEO

Forward Looking Statements

Certain statements contained in this press release constitute “forward-looking statements” within the meaning of applicable securities laws. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the terms of the Offering, the anticipated closing date of the Offering, the use of proceeds of the Offering, the Company’s strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company’s MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The Canadian Securities Exchange has not reviewed or approved the contents of this press release.

¹ Units sold according to BC wholesale data (Q4 2021)

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

RED DEER, AB, April 6, 2021 /CNW/ – Stigma Grow (“Stigma” or the “Company”) and its parent company, CanadaBis Capital Inc. (TSXV: CANB), are thrilled to announce they have entered into a third-party production agreement (the “Agreement”) with Sundial Growers Inc. (NASDAQ: SNDL) (“Sundial” or the “Company”), a Health Canada licensed cannabis producer recognized for its ‘small-batch-at-scale’ individualized ‘room’ approach, to produce a variety of Sundial’s hydrocarbon (BHO) concentrates.

Among other opportunities within the concentrates market, the new collaboration between the two Alberta-based companies will enable capitalization on the fast-emerging live-resin vape market.

Under the terms of the Agreement, Sundial will provide its input for both fresh-frozen and cured formats to Stigma to produce a variety of live-resin and cured cannabis concentrates.

Sundial expects to launch the products across Canada under the Top Leaf brand in Q3 2021.

“As one of the first-to-market producers of true live-resin, high-terpene, full-spectrum vape cartridges in Alberta we reviewed many partnership requests from some of legal cannabis’ most recognizable brands, but none provided the brand and business fit demonstrated by Sundial,” said Travis McIntyre, CEO of Stigma. “We look forward to working with this well-established Alberta brand long into the future and recognize the value that comes to those who partner strategically with like-minded visionaries.”

“As part of our continued focus within the premium inhalable segment, we are pleased to enter into a concentrates partnership with Stigma,” added Andrew Stordeur, President and Chief Operating Officer of Sundial.  “We believe this collaboration will provide our consumers with an excellent addition to our portfolio of cannabis products.”

In addition to this partnership announcement, the first two months of 2021 has seen the Company’s existing and new products accepted into Ontario, British Columbia, Manitoba and Saskatchewan, as education surrounding the quality and experience offered by live-resin concentrates makes its way across the country to millions of recreational and medicinal consumers typically looking for something new and improved.

About CanadaBis Capital Inc. & Stigma Grow

CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated Canadian cannabis company focused on achieving large-scale growth in the global cannabis market – with specific attention paid to supplying the fast-emerging concentrates category through their Stigma Grow cultivation and extraction facility.

Acting as the cornerstone for everything they offer, Stigma Grow continuously strives to address the market demands and lingering stigmas within the legal cannabis industry head-on, with products designed to disturb the status quo and dramatically shift the conversation surrounding Canada’s legal cannabis industry.

About Sundial Growers Inc. 

Sundial is a public company with Common Shares traded on Nasdaq under the symbol “SNDL”.

Sundial is a licensed producer that crafts cannabis using state-of-the-art indoor facilities. Our ‘craft-at-scale’ modular growing approach, award-winning genetics and experienced growers set us apart.

Our Canadian operations cultivate small-batch cannabis using an individualized “room” approach, with 448,000 square feet of total available space.

Sundial’s brand portfolio includes Top Leaf, Sundial Cannabis, Palmetto and Grasslands. Our consumer-packaged goods experience enables us to not just grow quality cannabis, but also to create exceptional consumer and customer experiences.

We are proudly Albertan, headquartered in Calgary, AB, with operations in Olds, AB, and Rocky View County, AB.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include but are not limited to statements with respect to our business and operations; timing of the Sundial products coming to market; the demand and market for live-resin vape cartridges, and our general business plans. Forward-looking statements are necessarily based upon a number of assumptions including: the ability of the Company’s products to compete with the pricing and product availability on the black-market; the market demand for the Company’s products; and assumptions concerning the Company’s competitive advantages. These assumptions, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: compliance with extensive government regulation, the general business, economic, competitive, political and social uncertainties; ability to sustain or create a demand for a product; requirement for further capital; delay or failure to receive board, shareholder or regulatory approvals; the results of operations and such other matters as set out in the Company’s continuous disclosure on SEDAR at www.sedar.com. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.

Accordingly, readers should not place undue reliance on forward-looking statements. Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although we believe that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have a material adverse effect on our future results, performance or achievements.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE CanadaBis Capital Inc.

For further information: For more information on CanadaBis Capital or Stigma Grow visit: www.canadabis.com, www.stigmagrow.ca, or contact: Investor Relations [email protected] 1-888-STIGMA1

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.